Chris Calise - Aug 23, 2023 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Christopher Calise
Stock symbol
COEP
Transactions as of
Aug 23, 2023
Transactions value $
$10,879
Form type
4
Date filed
8/31/2023, 04:01 PM
Previous filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $8.46K +9K +0.62% $0.94 1.46M Aug 23, 2023 Direct F1
transaction COEP Common Stock Purchase $2.42K +2.58K +0.18% $0.94 1.46M Aug 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.